Pharma - Softgel
Pharma - Softgel
PHILALPHA
Therapeutic Category
Agents for osteoporosis
Composition
Alfacalcidol 0.25 mcg, 0.5 mcg, 1 mcg
Indication
Renal osteodystrophy, osteoporosis, hyperparathyroidism, hypoparathyroidism,
hypophosphataemic vitamin D resistant rickets and osteomalacia.
Dosage & administration
0.5-1 mcg daily, the dose should be adjusted to avoid hypercalcemia,
according to the biochemical response
Shelf life
36 months